Conference Coverage

European hypertension guidelines help fill U.S. void


 

EXPERT ANALYSIS FROM THE ESC CONGRESS 2013

Dr. Smith and Dr. Williams said that they had no relevant disclosures. Dr. Mancia said that he has been a consultant to 14 drug and device companies. Dr. Renata Cífková said that she had been a consultant to Daiichi Sankyo, Teva, Zentiva, Merck Sharpe and Dohme, Actavis, Berlin Chemie, Boehringer Ingelheim, and Bayer. Dr. Marx said that he has been a consultant to 13 drug and device companies. Dr. Williams said that he has been a consultant to Pfizer, Merck, Sanofi-BMS, and Novartis.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Advise lifestyle change to obese but metabolically healthy women
MDedge Endocrinology
Gestational diabetes linked to sleep apnea
MDedge Endocrinology
After 15 years, UKPDS sulfonylurea-metformin combo shows no mortality bump
MDedge Endocrinology
Diabetics face increased treatment-resistant hypertension risk
MDedge Endocrinology
Think exercise first for secondary prevention?
MDedge Endocrinology
USPSTF: No evidence for routine blood pressure screening in children
MDedge Endocrinology
AHA: Docs must tackle patient smoking, obesity, poor diet, and inactivity
MDedge Endocrinology
Bariatric surgery cuts long-term diabetes complications
MDedge Endocrinology
Study hints at obesity paradox in older women with coronary artery disease
MDedge Endocrinology
Inherently low triglycerides may lower mortality
MDedge Endocrinology